Medical Access in Ireland

Psilocin is Schedule 1, and fungi containing psilocin or an ester of psilocin have been expressly controlled since 2006. Lawful activity is tightly restricted, with Ireland-linked psilocybin work currently research-led rather than routine care. [1]Ireland Misuse of Drugs Designation Order 2017 [2]Ireland Misuse of Drugs Amendment Regulations 2006 [3]Trinity COMP360 phase 2b news

No Irish authorised MDMA medicine or reimbursement pathway was identified. University materials reference sponsored PTSD work, but that remains investigational rather than routine care. [1]Trinity psychedelic clinical projects [2]Ireland Misuse of Drugs Designation Order 2017

Spravato is EMA-authorised and listed in Irish medicines information. NCPE states that HSE approved reimbursement after confidential price negotiations in January 2022, indicating a real but specialist access route. [1]EMA Spravato EPAR [2]medicines.ie Spravato SPC [3]NCPE Spravato HTA page

Ketamine is Schedule 3, not Schedule 1, and can circulate as a controlled medicinal product. Public Irish depression activity is most visible through ketamine research, including KARMA-Dep 2, rather than a standard reimbursement pathway for off-label depression care. [1]Ireland Misuse of Drugs Regulations 2017 [2]PubMed KARMA-Dep 2 ketamine trial record

DMT is listed in Schedule 1. No Irish authorised treatment or reimbursement route was identified outside licensed research. [1]Ireland Misuse of Drugs Designation Order 2017

The safest public label is investigational or controlled-access only. GH001 is connected to an Irish-headquartered sponsor and published Phase IIb data, but the exact schedule mapping for 5-MeO-DMT should be manually checked before stronger legal wording is used. [1]PubMed GH001 mebufotenin trial record [2]Ireland Misuse of Drugs Designation Order 2017

The reviewed Irish materials did not establish an authorised ibogaine treatment or reimbursement route. Do not repeat blanket Schedule 1 wording unless the current consolidated statutory basis is manually confirmed. [1]Ireland Misuse of Drugs Designation Order 2017

DMT is Schedule 1 and no official Irish ceremonial, medical or reimbursement pathway for ayahuasca was identified in reviewed sources. [1]Ireland Misuse of Drugs Designation Order 2017

Mescaline is listed in Schedule 1. No Irish authorised treatment or reimbursement route was identified outside licensed research. [1]Ireland Misuse of Drugs Designation Order 2017

Ireland's Schedule 1 framework includes many phenethylamine derivatives, but the exact mapping for each 2C-family compound should be checked before publication. No authorised treatment or reimbursement route was identified. [1]Ireland Misuse of Drugs Designation Order 2017